| Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice M Drab, P Verkade, M Elger, M Kasper, M Lohn, B Lauterbach, J Menne, ... science 293 (5539), 2449-2452, 2001 | 1929 | 2001 |
| Terminal complement inhibitor eculizumab in atypical hemolytic–uremic syndrome CM Legendre, C Licht, P Muus, LA Greenbaum, S Babu, C Bedrosian, ... New England Journal of Medicine 368 (23), 2169-2181, 2013 | 1629 | 2013 |
| Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes H Haller, S Ito, JL Izzo Jr, A Januszewicz, S Katayama, J Menne, ... New England Journal of Medicine 364 (10), 907-917, 2011 | 1080 | 2011 |
| Erythropoietin regulates endothelial progenitor cells FH Bahlmann, K De Groot, JM Spandau, AL Landry, B Hertel, T Duckert, ... Blood 103 (3), 921-926, 2004 | 712 | 2004 |
| Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients K Heusser, J Tank, S Engeli, A Diedrich, J Menne, S Eckert, T Peters, ... Hypertension 55 (3), 619-626, 2010 | 509 | 2010 |
| Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study IJM Scheffers, AA Kroon, J Schmidli, J Jordan, JJM Tordoir, MG Mohaupt, ... Journal of the American College of Cardiology 56 (15), 1254-1258, 2010 | 492 | 2010 |
| Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104: H4 induced haemolytic uraemic syndrome: case-control study J Menne, M Nitschke, R Stingele, M Abu-Tair, J Beneke, J Bramstedt, ... Bmj 345, 2012 | 343 | 2012 |
| Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial F Fakhouri, M Hourmant, JM Campistol, SR Cataland, M Espinosa, ... American journal of kidney diseases 68 (1), 84-93, 2016 | 302 | 2016 |
| ADMA increases arterial stiffness and decreases cerebral blood flow in humans JT Kielstein, F Donnerstag, S Gasper, J Menne, A Kielstein, ... Stroke 37 (8), 2024-2029, 2006 | 286 | 2006 |
| Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series J Brinkmann, K Heusser, BM Schmidt, J Menne, G Klein, J Bauersachs, ... Hypertension 60 (6), 1485-1490, 2012 | 274 | 2012 |
| Uremia causes endothelial progenitor cell deficiency K De Groot, FH Bahlmann, J Sowa, J Koenig, J Menne, H Haller, D Fliser Kidney international 66 (2), 641-646, 2004 | 261 | 2004 |
| Diagnosis and prediction of CKD progression by assessment of urinary peptides JP Schanstra, P Zürbig, A Alkhalaf, A Argiles, SJL Bakker, J Beige, ... Journal of the American Society of Nephrology 26 (8), 1999-2010, 2015 | 251 | 2015 |
| Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure FH Bahlmann, R Song, SM Boehm, M Mengel, R von Wasielewski, ... Circulation 110 (8), 1006-1012, 2004 | 236 | 2004 |
| Monocyte chemoattractant protein-1 and the kidney H Haller, A Bertram, F Nadrowitz, J Menne Current opinion in nephrology and hypertension 25 (1), 42-49, 2016 | 195 | 2016 |
| CC motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria J Menne, D Eulberg, D Beyer, M Baumann, F Saudek, Z Valkusz, ... Nephrology Dialysis Transplantation 32 (2), 307-315, 2017 | 193 | 2017 |
| Postischemic acute renal failure is reduced by short-term statin treatment in a rat model F Gueler, S Rong, JK Park, A Fiebeler, J Menne, M Elger, DN Mueller, ... Journal of the American Society of Nephrology 13 (9), 2288-2298, 2002 | 181 | 2002 |
| Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-α—Deficient diabetic mice J Menne, JK Park, M Boehne, M Elger, C Lindschau, T Kirsch, M Meier, ... Diabetes 53 (8), 2101-2109, 2004 | 176 | 2004 |
| Complement 5a receptor inhibition improves renal allograft survival F Gueler, S Rong, W Gwinner, M Mengel, V Bröcker, S Schön, TF Greten, ... Journal of the American Society of Nephrology 19 (12), 2302-2312, 2008 | 154 | 2008 |
| Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: a systematic review and meta-analysis J Menne, E Dumann, H Haller, BMW Schmidt PLoS medicine 16 (12), e1002983, 2019 | 150 | 2019 |
| The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment E Rondeau, M Scully, G Ariceta, T Barbour, S Cataland, N Heyne, ... Kidney international 97 (6), 1287-1296, 2020 | 149 | 2020 |
